Clinical efficacy of TACE plus HIFU in treatment of hepatocellular carcinoma at middle-late stage
返回论文页
|更新时间:2023-12-18
|
Clinical efficacy of TACE plus HIFU in treatment of hepatocellular carcinoma at middle-late stage
Journal of Chongqing Medical UniversityVol. 36, Issue 2, Pages: 179-181(2013)
作者机构:
青海大学附属医院介入科,西宁,810001
作者简介:
基金信息:
DOI:
CLC:
Published:2013,
扫 描 看 全 文
MA Cunkai, GUO Yingxing. Clinical efficacy of TACE plus HIFU in treatment of hepatocellular carcinoma at middle-late stage. [J]. Journal of Chongqing Medical University 36(2):179-181(2013)
DOI:
MA Cunkai, GUO Yingxing. Clinical efficacy of TACE plus HIFU in treatment of hepatocellular carcinoma at middle-late stage. [J]. Journal of Chongqing Medical University 36(2):179-181(2013)DOI:
Clinical efficacy of TACE plus HIFU in treatment of hepatocellular carcinoma at middle-late stage
Objective:To determine the clinical value of transarterial chemotherapy embolization(TACE) plus high-intensity focused ultrasound(HIFU) in the treatment of hepatocellular carcinoma at middle-late stage. Methods:Totally 138 patients with hepatocellu-lar carcinoma at middle-late stage were devided into two groups. Patients in treatment group were treated by TACE plus HIFU while those in control group were treated by TACE only. Therapeutic effects were observed. Results:Symptoms and signs were allivated,tu-mor size was narrowed and 3-year survival rate was improved in treatment group compared with those in control group,with statisti-cally differences between the two groups(P<0.05). Conclusions:TACE plus HIFU is an effective treatment method for hepatocellular carcinoma at middle-late stage.
关键词
原发性肝癌经肝动脉化疗栓塞术高强度超声聚焦刀
Keywords
primary carcinoma of the livertransarterial chemotherapy embolizationhigh-intensity focused ultrasound